6-methoxy-3-(3-methylphenyl)coumarin | 949580-60-3

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 异黄酮类化合物
• 英文名称: 6-methoxy-3-(3-methylphenyl)coumarin
• 英文别名: 6-methoxy-3-m-tolylchromen-2-one；6-Methoxy-3-(3-methylphenyl)chromen-2-one
• CAS: 949580-60-3
• 化学式: C₁₇H₁₄O₃
• 分子量: 266.296
• InChiKey: QPPLXIMUBLSEBJ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.9
• 重原子数：
  20
• 可旋转键数：
  2
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.12
• 拓扑面积：
  35.5
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  6-methoxy-3-(3-methylphenyl)coumarin 在 N-溴代丁二酰亚胺(NBS) 、 过氧化苯甲酰 作用下， 以 四氯化碳 为溶剂， 反应 6.0h， 以67%的产率得到3-(3-bromomethylphenyl)-6-methoxychromen-2-one
  参考文献：
  名称：

  Extensive SAR and Computational Studies of 3-{4-[(Benzylmethylamino)methyl]phenyl}-6,7-dimethoxy-2H-2-chromenone (AP2238) Derivatives

  摘要：

  AP2238 was the first compound published to bind both anionic sites of the human acetylcholinesterase, allowing the simultaneous inhibition of the catalytic and the amyloid-beta pro-aggregating activities of AChE. Here we attempted to derive a comprehensive structure-activity relationship picture for this molecule, affording 28 derivatives for which AChE and BChE inhibitory activities were evaluated. Selected compounds were also tested for their ability to prevent the AChE-induced A beta-aggregation. Moreover, docking simulations and molecular orbital calculations were performed.

  DOI：

  10.1021/jm070100g
• 作为产物：
  描述：

  2-羟基-5-甲氧基苯甲醛 、 3-甲基苯乙酸 在 N,N'-二环己基碳二亚胺 作用下， 以 二甲基亚砜 为溶剂， 反应 24.0h， 以79%的产率得到6-methoxy-3-(3-methylphenyl)coumarin
  参考文献：
  名称：

  Synthesis and adenosine receptors binding affinities of a series of 3-arylcoumarins

  摘要：

  摘要：在这份研究中，我们报告了一系列选定的3-芳基香豆素化合物（化合物1-9）的合成、药理评价、吸收、分布、代谢和排泄性质的理论评价以及构效关系研究。我们对合成的化合物1-9进行了腺苷受体（ARs）结合活性和选择性评估。在评估的骨架的苯环中引入了不同的取代基，分别位于6位和3'或4'位置。对3-芳基香豆素骨架缺乏数据促使我们探索一系列衍生物的ARs结合活性。 方法：合成了一系列新的香豆素化合物（化合物1-9），并通过放射配体结合研究评估其对ARs的结合。 主要发现：分析实验数据，可以观察到简单的3-芳基香豆素和4'-硝基衍生物对评估的受体没有可检测的结合亲和力，尽管大多数其他取代衍生物具有良好的结合亲和力特性，特别是对hA1/hA3或仅hA3 AR。 结论：最显著的衍生物是化合物2，对hA3 AR具有最佳亲和力（Ki = 2680 nM），并对这个亚型具有显著的选择性。

  DOI：

  10.1111/jphp.12135

文献信息

• Synthesis and Study of a Series of 3-Arylcoumarins as Potent and Selective Monoamine Oxidase B Inhibitors
  作者：Maria J. Matos、Carmen Terán、Yunierkis Pérez-Castillo、Eugenio Uriarte、Lourdes Santana、Dolores Viña

  DOI：10.1021/jm200716y

  日期：2011.10.27

  New series of 6-substituted-3-arylcoumarins displaying several alkyl, hydroxyl, halogen, and alkoxy groups in the two benzene rings have been designed, synthesized, and evaluated in vitro as human monoamine cuddase A and B (hMAO-A and hMAO-B) inhibitors. Most of the studied compounds showed a high affinity and selectivity to the hMAO-B isoenzyme, with IC50 values on nanomolar and picomolar range. Ten of the 22 described compounds displayed higher MAO-B inhibitory activity and selectivity than selegiline. Coumarin 7 is the most active compound of this series, being 64 times more active than selegiline and also showing the highest hMAO-B specificity. In addition, docking experiments were carried out on hMAO-A and h-MAO-B structures. This study provided new information about the enzyme inhibitor interaction and the potential therapeutic application of this 3-arylcoumarin scaffold.
• Extensive SAR and Computational Studies of 3-{4-[(Benzylmethylamino)methyl]phenyl}-6,7-dimethoxy-2<i>H</i>-2-chromenone (AP2238) Derivatives
  作者：Lorna Piazzi、Andrea Cavalli、Federica Belluti、Alessandra Bisi、Silvia Gobbi、Stefano Rizzo、Manuela Bartolini、Vincenza Andrisano、Maurizio Recanatini、Angela Rampa

  DOI：10.1021/jm070100g

  日期：2007.8.1

  AP2238 was the first compound published to bind both anionic sites of the human acetylcholinesterase, allowing the simultaneous inhibition of the catalytic and the amyloid-beta pro-aggregating activities of AChE. Here we attempted to derive a comprehensive structure-activity relationship picture for this molecule, affording 28 derivatives for which AChE and BChE inhibitory activities were evaluated. Selected compounds were also tested for their ability to prevent the AChE-induced A beta-aggregation. Moreover, docking simulations and molecular orbital calculations were performed.
• Synthesis and adenosine receptors binding affinities of a series of 3-arylcoumarins
  作者：Maria João Matos、Veronika Hogger、Alexandra Gaspar、Sonja Kachler、Fernanda Borges、Eugenio Uriarte、Lourdes Santana、Karl-Norbert Klotz

  DOI：10.1111/jphp.12135

  日期：2013.10.14

  In the present communication, we report the synthesis, pharmacological evaluation, theoretical evaluation of absorption, distribution, metabolism and excretion properties and structure–activity relationship study of a selected series of 3-arylcoumarins (compounds 1–9). Adenosine receptors (ARs) binding activity and selectivity of the synthesized compounds 1–9 were evaluated in this study. Different substituents were introduced in both benzene rings of the evaluated scaffold, at positions 6 and 3′ or 4′ of the moiety. The lack of data on the 3-arylcoumarin scaffold encouraged us to explore the ARs' binding activity of a selected series of derivatives.

  A new series of coumarins (compounds 1–9) were synthesized and evaluated by radioligand binding studies towards ARs.

  Analysing the experimental data, it can be observed that neither the simple 3-arylcoumarin nor the 4′-nitro derivatives presented detectable binding affinity for the evaluated receptors, although most of the other substituted derivatives have good binding affinity profiles, especially against the hA1/hA3 or only hA3 AR.

  The most remarkable derivative is compound 2, presenting the best affinity for hA3 AR (Ki = 2680 nM) and significant selectivity for this subtype.

  摘要：在这份研究中，我们报告了一系列选定的3-芳基香豆素化合物（化合物1-9）的合成、药理评价、吸收、分布、代谢和排泄性质的理论评价以及构效关系研究。我们对合成的化合物1-9进行了腺苷受体（ARs）结合活性和选择性评估。在评估的骨架的苯环中引入了不同的取代基，分别位于6位和3'或4'位置。对3-芳基香豆素骨架缺乏数据促使我们探索一系列衍生物的ARs结合活性。 方法：合成了一系列新的香豆素化合物（化合物1-9），并通过放射配体结合研究评估其对ARs的结合。 主要发现：分析实验数据，可以观察到简单的3-芳基香豆素和4'-硝基衍生物对评估的受体没有可检测的结合亲和力，尽管大多数其他取代衍生物具有良好的结合亲和力特性，特别是对hA1/hA3或仅hA3 AR。 结论：最显著的衍生物是化合物2，对hA3 AR具有最佳亲和力（Ki = 2680 nM），并对这个亚型具有显著的选择性。